866-997-4948(US-Canada Toll Free)

Published on : Jan 23, 2017

Albany, New York, January 23, 2017: ResearchMoz.us has announced the addition of a new research report, titled “Cervical Cancer Test Market & Patients (Pap Smear HPV DNA VIA) Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia),” to its offerings. The report provides a 360-degree view of the Asia cervical cancer test market. The statistics pertaining to the market are presented at both Asia and country-wise levels. Countries which are analyzed in the report are Thailand, India, Japan, Indonesia, China, Malaysia, Korea, and Singapore.

The rising prevalence of cervical cancer is by far the leading factor driving the Asia cervical cancer test market. The increasing incidence of human papillomavirus (HPV) infections is leading to the greater uptake of HPV testing, which in turn is fuelling the market. HPV may progress from a low-grade disease to a high-grade disease, which is sometimes associated with cervical cancer. The introduction of low-cost visual inspection with acetic acid (VIA) test is another factor augmenting the market.

Moreover, governments are increasingly introducing programs that are promoting awareness regarding cervical cancer screening programs, which in turn is providing a significant push to the market. Other than awareness programs, governments are also pouring funds into the research and development of screening kits and devices, which is working in favor of the growth of the cervical cancer test market in Asia.

Click to get more details with TOC in a PDF Format: http://www.researchmoz.us/enquiry.php?type=S&repid=910650

On the flip side, the lack of appropriate primary healthcare infrastructure is hampering the growth of the market. In countries such as India and Indonesia, there are a limited number of health clinics for the test and treatment for cervical cancer. Despite several awareness programs by governments, the awareness levels are low, particularly in rural areas, which is limiting the widespread adoption of cervical cancer tests. However, the advent of breakthrough products and technologies is likely to shape the future of the market in Asia. Moreover, the increasing efforts by global players in strengthening distribution networks in the region are creating tremendous growth opportunities for the market.

On the basis of test type, the Asia cervical cancer test market can be segmented into Papanicolaou (Pap) smear test, HPV DNA test, and VIA test. The demand for Pap smear test is expected to remain high throughout the forecast period owing to high-cost efficiency and reliability of the test and growing awareness regarding cancer diagnosis. The HPV DNA test segment is anticipated to exhibit a noteworthy CAGR in the forthcoming years owing to the rising incidence of HPV and other sexually transmittable infections that can potentially cause cervical cancer.

Players in the Asia cervical cancer test market are primarily focusing on technological advancements and product upgradation in order to gain an edge over their peers in this highly competitive arena. Some of the prominent players in the market are Becton Dickinson and Company, Abbott Laboratories, and Hologic Inc.

To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on sales@researchmoz.us